A study published in Cancer Research (May 1, 2009; Volume 69, Issue 9, Pages 3833–3841) examined the relationship between vitamin E status and prostate cancer survival. The analysis was conducted within the α-Tocopherol, β-Carotene Cancer Prevention (ATBC) Study cohort.
Among 1,891 men diagnosed with prostate cancer, 395 died from the disease during the follow-up period. Researchers found that men with higher blood levels of α-tocopherol (vitamin E) had improved survival. Participants in the highest quintile of vitamin E status—the top 20%—had a 49% lower risk of prostate cancer–specific mortality compared with those in the lowest quintile.
These findings suggest that higher vitamin E status was associated with improved prostate cancer survival in this population.
